- Home
- BMRN vs HTHT Comparison
BMRN vs HTHT Comparison
Compare BMRN & HTHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BMRN | HTHT |
|---|---|---|
| Founded | 1996 | 2005 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.0B | 13.6B |
| IPO Year | 1999 | 2010 |
Fundamental Metrics
Financial Performance| Metric | BMRN | HTHT |
|---|---|---|
| Price | $66.53 | $45.77 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 4 |
| Target Price | ★ $88.22 | $56.60 |
| AVG Volume (30 Days) | ★ 2.2M | 1.5M |
| Earning Date | 05-04-2026 | 05-19-2026 |
| Dividend Yield | N/A | ★ 4.07% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.77 | N/A |
| Revenue | ★ $1,313,646,000.00 | N/A |
| Revenue This Year | $15.02 | $7.18 |
| Revenue Next Year | $12.23 | $6.71 |
| P/E Ratio | $86.55 | ★ $30.34 |
| Revenue Growth | ★ 17.62 | N/A |
| 52 Week Low | $49.26 | $36.56 |
| 52 Week High | $70.98 | $56.53 |
Technical Indicators
Market Signals| Indicator | BMRN | HTHT |
|---|---|---|
| Relative Strength Index (RSI) | 56.83 | 52.08 |
| Support Level | $58.03 | $40.37 |
| Resistance Level | $70.98 | $50.45 |
| Average True Range (ATR) | 1.56 | 1.24 |
| MACD | -0.34 | -0.21 |
| Stochastic Oscillator | 46.31 | 26.40 |
Price Performance
Historical ComparisonAbout BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About HTHT H World Group Limited
H World Group Ltd a foremost, fast-growing multi-brand hotel group with international operations. The principal business activities of the Company are to develop and operate leased and owned, manachised and franchised hotels mainly in the PRC or PRC Mainland. The Group has two operating segments which are legacy Huazhu and legacy DH according to the way management intends to evaluate results and allocate resources within the Group. The majority of revenue comes from legacy Huazhu. The company has presence in Greater China and also Outside Greater China.